Any book about life science innovation that starts with quotes from Frank Zappa and Albert Einstein promises to be a good read.
The Biologist’s Imagination holds to that promise, as authors William Hoffman and Leo Furcht, both of the University of... Read more »
LabCorp (NYSE: LH), already one of the largest laboratory testing and diagnostics companies in the nation, plans to further expand its reach into clinical trials by buying contract research organization Covance (NYSE: CVD) in a deal valued at approximately... Read more »
[Updated 11/3/14, 2:50 p.m., to include comments from Hopster and Inmar executives.] In another exit for Wisconsin serial entrepreneur Brian Wiegand, e-commerce technology provider Inmar has acquired Wiegand’s digital coupon startup Hopster for an undisclosed price.
This marks the... Read more »
Two years ago, no one could’ve predicted the worst Ebola outbreak in history would hit West Africa this year. And Lucigen—a small Wisconsin life sciences company with a federal grant to develop a simpler, faster test for diagnosing serious pathogens—certainly didn’t... Read more »
Immigration policy reform is a hot-button issue right now, but it’s affecting the innovation economy in unexpected ways.
U.S. companies are having a hard time recruiting enough skilled workers to fill all their high-level science, tech, and engineering positions. I discussed... Read more »
Ralph Kauten, one of Wisconsin’s more successful biotech entrepreneurs, was named CEO of Lucigen, a local life sciences supplier that is developing technology to rapidly identify pathogens, including Ebola.
Kauten takes over for molecular biologist David Mead, who has served... Read more »
Irish entrepreneur Michael FitzGerald still gets calls from investors and potential partner companies in the U.S. who ask him “How’s Dublin?” when making small talk—even though his startup, OnePageCRM, is located a two-hour drive west in the coastal city of... Read more »